Organogenesis Holdings Inc. (ORGO)

USD 4.33

(1.64%)

Revenue Summary of Organogenesis Holdings Inc.

  • Organogenesis Holdings Inc.'s latest annual revenue in 2023 was 433.14 Million USD , down -3.94% from previous year.
  • Organogenesis Holdings Inc.'s latest quarterly revenue in 2024 Q2 was 130.23 Million USD , up 18.42% from previous quarter.
  • Organogenesis Holdings Inc. reported a annual revenue of 450.89 Million USD in annual revenue 2022, down -3.67% from previous year.
  • Organogenesis Holdings Inc. reported a annual revenue of 468.05 Million USD in annual revenue 2021, up 38.36% from previous year.
  • Organogenesis Holdings Inc. reported a quarterly revenue of 109.97 Million USD for 2024 Q1, up 10.36% from previous quarter.
  • Organogenesis Holdings Inc. reported a quarterly revenue of 107.64 Million USD for 2023 Q1, down -6.82% from previous quarter.

Annual Revenue Chart of Organogenesis Holdings Inc. (2023 - 2016)

Historical Annual Revenue of Organogenesis Holdings Inc. (2023 - 2016)

Year Revenue Revenue Growth
2023 433.14 Million USD -3.94%
2022 450.89 Million USD -3.67%
2021 468.05 Million USD 38.36%
2020 338.29 Million USD 29.63%
2019 260.98 Million USD 34.91%
2018 193.44 Million USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%

Peer Revenue Comparison of Organogenesis Holdings Inc.

Name Revenue Revenue Difference
Collegium Pharmaceutical, Inc. 566.76 Million USD 23.577%
Embecta Corp. 1.12 Billion USD 61.354%
ANI Pharmaceuticals, Inc. 486.81 Million USD 11.026%
Dynavax Technologies Corporation 232.28 Million USD -86.47%
Esperion Therapeutics, Inc. 116.33 Million USD -272.325%
Pacira BioSciences, Inc. 674.97 Million USD 35.829%
PainReform Ltd. - USD -Infinity%
Aquestive Therapeutics, Inc. 50.58 Million USD -756.296%
Sunshine Biopharma, Inc. 24.09 Million USD -1697.799%
SCYNEXIS, Inc. 140.14 Million USD -209.074%
China SXT Pharmaceuticals, Inc. 1.92 Million USD -22359.978%
Cosmos Health Inc. 53.37 Million USD -711.475%
Journey Medical Corporation 79.18 Million USD -447.025%
Sunshine Biopharma, Inc. 24.09 Million USD -1697.799%
Safety Shot Inc 202.67 Thousand USD -213616.88%
Alpha Teknova, Inc. 36.68 Million USD -1080.733%
Intra-Cellular Therapies, Inc. 464.37 Million USD 6.725%
Bright Green Corporation 401.49 Thousand USD -107782.867%
Procaps Group, S.A. 409.92 Million USD -5.665%
Theratechnologies Inc. 81.76 Million USD -429.744%
Harrow Health, Inc. 130.19 Million USD -232.691%
Sonoma Pharmaceuticals, Inc. 12.73 Million USD -3301.178%
Biofrontera Inc. 34.07 Million USD -1171.286%
DURECT Corporation 8.54 Million USD -4967.15%
Supernus Pharmaceuticals, Inc. 607.52 Million USD 28.704%
Cronos Group Inc. 88.84 Million USD -387.546%
OptiNose, Inc. 70.98 Million USD -510.168%
Ironwood Pharmaceuticals, Inc. 442.73 Million USD 2.167%
Kala Pharmaceuticals, Inc. - USD -Infinity%
RedHill Biopharma Ltd. 6.51 Million USD -6550.215%
Guardion Health Sciences, Inc. 12.24 Million USD -3436.255%
Cumberland Pharmaceuticals Inc. 39.55 Million USD -995.101%
Radius Health, Inc. 2.88 Billion USD 84.972%
Universe Pharmaceuticals INC 32.3 Million USD -1240.628%
ProPhase Labs, Inc. 44.38 Million USD -875.892%
Phibro Animal Health Corporation 1.01 Billion USD 57.438%
Procaps Group S.A. 409.92 Million USD -5.665%
Alvotech 91.43 Million USD -373.719%
TherapeuticsMD, Inc. 1.3 Million USD -33167.281%
Viatris Inc. 15.42 Billion USD 97.192%
Rockwell Medical, Inc. 83.61 Million USD -418.036%
Aytu BioPharma, Inc. 81 Million USD -434.728%
SIGA Technologies, Inc. 139.91 Million USD -209.569%
Tilray Brands, Inc. 788.94 Million USD 45.099%
Lifecore Biomedical, Inc. 128.26 Million USD -237.702%
Shineco, Inc. 9.8 Million USD -4318.959%
PetIQ, Inc. 1.1 Billion USD 60.694%
Regencell Bioscience Holdings Limited - USD -Infinity%
Incannex Healthcare Limited 12 Thousand USD -3609400.0%
Neurocrine Biosciences, Inc. 1.88 Billion USD 77.047%
Alimera Sciences, Inc. 80.75 Million USD -436.37%
Silver Spike Investment Corp. 11.72 Million USD -3595.061%
Assertio Holdings, Inc. 152.06 Million USD -184.831%
Shuttle Pharmaceuticals Holdings, Inc. - USD -Infinity%
Petros Pharmaceuticals, Inc. 5.82 Million USD -7339.216%
Clever Leaves Holdings Inc. 17.41 Million USD -2386.881%
Cyclo Therapeutics, Inc. 1.07 Million USD -40139.501%
Avadel Pharmaceuticals plc 27.96 Million USD -1448.975%
Hempacco Co., Inc. 4.04 Million USD -10606.349%
Talphera, Inc. 651 Thousand USD -66434.562%
Alvotech 91.43 Million USD -373.719%
Eagle Pharmaceuticals, Inc. 316.61 Million USD -36.806%
Lantheus Holdings, Inc. 1.29 Billion USD 66.59%
Currenc Group, Inc. 53.25 Million USD -713.327%
Kamada Ltd. 144.75 Million USD -199.215%
Indivior PLC 1.09 Billion USD 60.371%
Evoke Pharma, Inc. 5.18 Million USD -8260.759%
Flora Growth Corp. 76.07 Million USD -469.389%
Cyclo Therapeutics, Inc. 1.07 Million USD -40139.501%
Evolus, Inc. 202.08 Million USD -114.336%
HUTCHMED (China) Limited 837.99 Million USD 48.313%
Amphastar Pharmaceuticals, Inc. 644.39 Million USD 32.783%
Akanda Corp. 2.16 Million USD -19952.295%